Immunotherapy Research in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Immunotherapy Research in Mexico

Immunotherapy Research in Mexico – CRO South America

Immunotherapy, a groundbreaking field in medical science, has revolutionized the landscape of cancer treatment worldwide. By harnessing the power of the body’s immune system, immunotherapy offers a promising avenue for more effective and targeted cancer therapies.

In recent years, Mexico has emerged as a hub for innovative immunotherapy research, contributing significantly to advancements in this field. This blog will delve into the remarkable progress made in immunotherapy research in Mexico and highlight some key initiatives and breakthroughs that have the potential to transform cancer treatment globally.

The Rise of Immunotherapy Research in Mexico:

In the past decade, Mexico has witnessed a remarkable rise in immunotherapy research, with numerous academic institutions, research centers, and hospitals leading the way. These institutions have dedicated substantial resources and efforts to understand the mechanisms behind immunotherapy and develop novel treatment approaches.

This surge in research activity has attracted top-tier scientists, medical professionals, and industry experts, creating a vibrant ecosystem for collaboration and innovation.

Collaboration and Partnerships:

One key factor contributing to the success of immunotherapy research in Mexico is the emphasis on collaboration and partnerships. Academic institutions, such as the National Autonomous University of Mexico (UNAM), the Mexican Institute of Social Security (IMSS), and the National Institute of Cancerology (INCan), actively collaborate with international research centers and pharmaceutical companies.

These partnerships facilitate knowledge exchange, access to cutting-edge technologies, and the development of clinical trials, ultimately accelerating progress in immunotherapy research.

Development of Innovative Immunotherapies:

Mexico has made significant strides in the development of innovative immunotherapies for various types of cancer. Researchers in Mexico are focusing on developing vaccines, immune checkpoint inhibitors, adoptive cell therapies, and other groundbreaking treatments.

For example, scientists at INCan have been conducting extensive research on cancer vaccines that stimulate the immune system to target and eliminate cancer cells. Their efforts have shown promising results in clinical trials, bringing hope to patients in Mexico and beyond.

Immunotherapy Research in Mexico

Immunotherapy Research in Mexico

Immunotherapy Research in Mexico

Tailoring Immunotherapy to the Mexican Population:

Immunotherapy research in Mexico is also characterized by an emphasis on understanding the unique genetic and environmental factors that influence cancer development in the Mexican population.

By tailoring immunotherapeutic approaches to the specific needs and characteristics of Mexican patients, researchers aim to optimize treatment outcomes and address healthcare disparities. This personalized approach ensures that immunotherapy is accessible and effective for a broader patient population.

Clinical Trials and Patient Access:

Mexico has become an attractive destination for conducting clinical trials in immunotherapy. The country’s robust regulatory framework, diverse patient population, and excellent healthcare infrastructure make it an ideal location for testing and validating novel immunotherapeutic interventions. Clinical trials not only provide Mexican patients with access to cutting-edge treatments but also contribute valuable data to global research efforts.

Challenges and Future Directions:

While immunotherapy research in Mexico has made remarkable progress, several challenges persist. These include the need for increased funding, strengthening research infrastructure, and enhancing collaboration between academia, industry, and government agencies. Addressing these challenges will require sustained efforts and continued investment in scientific research and innovation.

Looking ahead, the future of immunotherapy research in Mexico is incredibly promising. The country’s dedication to scientific advancement, the presence of world-class research institutions, and the commitment of researchers and healthcare professionals bode well for further breakthroughs in cancer treatment.

By expanding clinical trials, fostering international collaborations, and prioritizing patient-centric approaches, Mexico has the potential to become a global leader in immunotherapy research and contribute significantly to the fight against cancer.


Immunotherapy research in Mexico has made significant strides, positioning the country as a leading player in the development of innovative cancer treatments. Through collaboration, scientific excellence, and a focus on personalized medicine, Mexico is driving advancements in immunotherapy that have the potential to transform cancer treatment not only within its borders but also on a global scale.

With a strong emphasis on collaboration, partnerships, and tailoring treatments to the Mexican population, researchers are paving the way for improved patient outcomes and a more targeted approach to cancer therapy.

Immunotherapy Research in Mexico

Source: Roche

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Immunotherapy Research in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Immunotherapy Research in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Immunotherapy Research in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Immunotherapy Research in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Immunotherapy Research in Mexico

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Immunotherapy Research in Mexico

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Immunotherapy Research in Mexico

The Cohortias Team

Immunotherapy Research in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Immunotherapy Research in Mexico

Network & Partnerships